Basophil Activation Test as Biomarker of Severity and Threshold of Allergic Reactions to Cow&apos;s Milk During Oral Food Challenges

Allergic Diseases

Biomarkers of Tolerance to Baked Milk in Cow's Milk-Allergic Children at High Risk of Anaphylaxis

J Investig Allergol Clin Immunol

Domínguez O, Riggioni C, Poyatos E, Jiménez-Feijoo RM, Piquer M, Machinena A, Folqué M, Ortiz de Landazuri I, Torradeflot M, Lozano J, Alsina L, Pascal M, Alvaro-Lozano M

doi: 10.18176/jiaci.1074

Allergic Diseases

Baked-Milk Modulates Cow's Milk Allergy in Children: Impact of Phenotype, Age, Intake

J Allergy Clin Immunol Pract

Domínguez O, Poyatos E, C Riggioni, Salamanca G, Jiménez-Feijoo RM, LozanoMD J, Piquer M, Machinena A, Folqué M, Ortiz de Landazuri I, Lasa M, Alsina L, Pascal M, Alvaro-Lozano M

doi: 10.1016/j.jaip.2025.06.011

Allergic Diseases

Epinephrine Nasal Spray Improves Allergic Symptoms in Patients Undergoing Oral Food Challenge, Phase 3 Trial

J Allergy Clin Immunol Pract

Ebisawa M, Takahashi K, Takahashi K, Yanagida N, Sato S, Lieberman J, Pistiner M, Spergel JM, Lowenthal R, Tanimoto S

doi: 10.1016/j.jaip.2025.06.038

Allergic DiseasesImmunotherapy

Decreased Severity of Oral Immunotherapy Induced Gastrointestinal Eosinophilic Reactions Following Revisions in Milk-Treatment Protocol

Allergy

Epstein-Rigbi N, Elkan M, Tzarfati Y, Levy MB, Nachshon L, Koren Y, Katz Y, Elizur A, Goldberg MR

doi: 10.1111/all.70165

Immunotherapy

Heat-treated egg allergens show lower basophil activation: A path toward safer oral immunotherapy

Pediatr Allergy Immunol

Paolucci M, Breiding M, Dietrich M, Meyer JG, Duda A, Köhli A, Lang CCV, Agah S, Wuenschmann S, Eyer K, Kündig TM, Trück J, Johansen P

doi: 10.1111/pai.70275

Allergic Diseases

Impact of oral immunotherapy on diversity of gut microbiota in food-allergic children

Pediatr Allergy Immunol

Bouabid T, Tremblay BL, Lavoie MÈ, Boucher-Lafleur AM, Gagnon-Brassard F, Bégin P, Lavoie S, Rochefort-Beaudoin C, Nuncio-Naud C, Parizeault G, Morin C, Girard C, Madore AM, Laprise C

doi: 10.1111/pai.70156

Allergic Diseases

Factors associated with false negative exercise provocation tests following exercise-induced allergic reactions in children desensitized to wheat

Pediatr Allergy Immunol

Mukai M, Matsui T, Kitamura K, Takasato Y, Sugiura S, Ito K

doi: 10.1111/pai.70274

Allergic DiseasesFurther Publications Immunology

Strategic Directions for Advancing Equity in Food Allergy: Takeaways from CFAAR's Summit for Advancing Equity in Food Allergy

J Allergy Clin Immunol Pract

Yang MS, Warren CM, Engel ML, Samady W, Sansweet SR, Kanaley MK, Folger EVW, Shankar S, Gupta RS, Bilaver LA

doi: 10.1016/j.jaip.2025.05.024

Allergic Diseases

Epicutaneous and Drug Provocation Testing in Severe Cutaneous Adverse Reactions: A 20-Year Single-Centre Experience

Contact Dermatitis

Chadli Z, Mansour K, Jaouahdou G, Belgacem MB, Soua Y, Fredj NB, Zili J, Romdhane HB, Aouam K

doi: 10.1111/cod.70118

Dermatology · Immunology · Rheumatology

Basophil Activation Test as Biomarker of Severity and Threshold of Allergic Reactions to Cow's Milk During Oral Food Challenges

Related content

Biomarkers of Tolerance to Baked Milk in Cow's Milk-Allergic Children at High Risk of Anaphylaxis

Baked-Milk Modulates Cow's Milk Allergy in Children: Impact of Phenotype, Age, Intake

Epinephrine Nasal Spray Improves Allergic Symptoms in Patients Undergoing Oral Food Challenge, Phase 3 Trial

Decreased Severity of Oral Immunotherapy Induced Gastrointestinal Eosinophilic Reactions Following Revisions in Milk-Treatment Protocol

Heat-treated egg allergens show lower basophil activation: A path toward safer oral immunotherapy

Impact of oral immunotherapy on diversity of gut microbiota in food-allergic children

Factors associated with false negative exercise provocation tests following exercise-induced allergic reactions in children desensitized to wheat

Strategic Directions for Advancing Equity in Food Allergy: Takeaways from CFAAR's Summit for Advancing Equity in Food Allergy

Epicutaneous and Drug Provocation Testing in Severe Cutaneous Adverse Reactions: A 20-Year Single-Centre Experience